ELAN Intrinsic Value Calculation – Elanco Animal Health Aims to Make Animals Even Healthier
December 22, 2023
🌥️Trending News
Elanco Animal Health ($NYSE:ELAN) is a leading global animal health company that strives to make animals healthier and produce healthier food for humans. The company works with farmers, veterinarians, pet owners, and food producers to improve the health and well-being of animals, while ensuring safe and nutritious food supplies. Elanco provides a range of products for companion animals, livestock, and aquaculture that are tailored to meet specific needs. The company’s mission is to make animals healthier by providing quality products that are safe and effective. Elanco aims to develop products that are scientifically sound and support the health of animals while being cost-effective. Their range of products includes vaccines, pharmaceuticals, nutritional supplements, and diagnostics that are designed to help keep animals healthy and strong.
Elanco also provides services such as nutrition consulting and veterinary education to help animals stay in optimum health. They use advanced research and development techniques to discover and develop new products that will benefit animals and their owners. Elanco is committed to creating a more sustainable future for the animal health industry. Their products and services are designed to create a healthier world for both animals and humans alike.
Price History
On Thursday, the company’s stock opened at $14.2 and closed at $14.5, up 3.6% from the prior closing price of $14.0. This is a sign of the company’s dedication to its mission of improving animal health and welfare. Elanco Animal Health focuses on supporting companion animal owners, veterinarians, and farmers alike in providing the best care and health for animals of all shapes and sizes. Elanco Animal Health continues to strive for the best innovations and solutions to enhance animal health and welfare. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for ELAN. More…
| Total Revenues | Net Income | Net Margin |
| 4.37k | -1.14k | 0.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for ELAN. More…
| Operations | Investing | Financing |
| 127 | -210 | -28 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for ELAN. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 14.34k | 8.21k | 12.45 |
Key Ratios Snapshot
Some of the financial key ratios for ELAN are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 14.4% | 49.3% | -20.3% |
| FCF Margin | ROE | ROA |
| -1.5% | -8.2% | -3.9% |
Analysis – ELAN Intrinsic Value Calculation
At GoodWhale, we recently conducted an analysis of ELANCO ANIMAL HEALTH’s wellbeing. Our proprietary Valuation Line estimates the fair value of ELANCO ANIMAL HEALTH share to be around $19.7. Unfortunately, the stock is currently trading at $14.5, which represents a 26.6% undervaluation. We believe that this presents a great opportunity for investors. More…
Peers
The company’s competitors include GeneFerm Biotechnology Co Ltd, Rhone Ma Holdings Bhd, and Phibro Animal Health Corp.
– GeneFerm Biotechnology Co Ltd ($TPEX:1796)
Ferm Biotechnology Co Ltd is a company that manufactures and sells biotechnology products. The company has a market cap of 2.34B as of 2022 and a return on equity of 9.05%. The company’s products are used in the healthcare, food and beverage, and industrial markets.
– Rhone Ma Holdings Bhd ($KLSE:5278)
Rhone Ma Holdings Bhd is a Malaysia-based investment holding company. The Company, through its subsidiaries, is engaged in the provision of management services, banking and financial services, and investment holding. The Company’s segments include Commercial Banking, which is engaged in the provision of banking products and services to small and medium enterprises (SMEs) and individuals; Treasury, which is engaged in the provision of foreign exchange and money market services; and Corporate Banking, which is engaged in the provision of financing solutions to SMEs and large corporations.
– Phibro Animal Health Corp ($NASDAQ:PAHC)
Phibro Animal Health Corp is a publicly traded company that focuses on animal health and nutrition. As of 2022, the company had a market capitalization of 505.49 million and a return on equity of 19.25%. Phibro Animal Health Corp was founded in 1947 and is headquartered in Teaneck, New Jersey. The company’s products include pharmaceuticals, vaccines, and nutritional supplements for livestock, poultry, and aquaculture.
Summary
Elanco Animal Health (ELAN) has been a popular stock amongst investors in recent months due to their strong performance in the animal health sector. Their market-leading portfolio and innovative strategies have paid off, with their stock price rising steadily over the last year. This trend has been further buoyed by the announcement of their strategic partnership with Bayer Animal Health and the acquisition of Bayer’s pet-care business, which is expected to increase Elanco’s market share.
The stock has also been further supported by their successful launch of new products and services in the animal health sector, along with their strong customer relationships. Investors in Elanco Animal Health have seen good returns in the past year, and can feel confident that this trend will continue in the future.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
